Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Continued control of pneumococcal disease in the UK - the impact of vaccination.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

J Med Microbiol. 2011 Jan;60(Pt 1):1-8. doi: 10.1099/jmm.0.020016-0. Epub 2010 Oct 21. Review.

PMID:
20965923
2.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

3.

13-valent pneumococcal conjugate vaccine (PCV13).

Jefferies JM, Macdonald E, Faust SN, Clarke SC.

Hum Vaccin. 2011 Oct;7(10):1012-8. doi: 10.4161/hv.7.10.16794. Epub 2011 Oct 1. Review.

PMID:
21941097
4.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
5.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.

Clin Infect Dis. 2008 Oct 15;47(8):989-96. doi: 10.1086/591966.

PMID:
18781875
6.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

7.

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.

Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC.

Vaccine. 2015 Apr 21;33(17):2015-21. doi: 10.1016/j.vaccine.2015.03.012. Epub 2015 Mar 14.

8.

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.

Roca A, Bojang A, Bottomley C, Gladstone RA, Adetifa JU, Egere U, Burr S, Antonio M, Bentley S, Kampmann B; Pneumo13 Study Group.

Vaccine. 2015 Dec 16;33(51):7144-7151. doi: 10.1016/j.vaccine.2015.11.012. Epub 2015 Nov 17.

9.

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.

Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC.

Vaccine. 2011 Jun 10;29(26):4400-4. doi: 10.1016/j.vaccine.2011.04.004. Epub 2011 Apr 17.

PMID:
21504773
10.

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.

van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.

Vaccine. 2014 Jul 23;32(34):4349-55. doi: 10.1016/j.vaccine.2014.03.017. Epub 2014 Mar 21.

PMID:
24657717
11.

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ.

BMC Infect Dis. 2010 Apr 8;10:90. doi: 10.1186/1471-2334-10-90.

12.

Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.

Nunes MC, Jones SA, Groome MJ, Kuwanda L, Van Niekerk N, von Gottberg A, de Gouveia L, Adrian PV, Madhi SA.

Vaccine. 2015 Jan 29;33(5):628-34. doi: 10.1016/j.vaccine.2014.12.023. Epub 2014 Dec 23.

PMID:
25541213
14.

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E.

PLoS Med. 2011 Apr;8(4):e1001017. doi: 10.1371/journal.pmed.1001017. Epub 2011 Apr 5.

15.

Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.

Ansaldi F, de Florentiis D, Canepa P, Zancolli M, Martini M, Orsi A, Durando P, Icardi G.

Vaccine. 2012 Mar 16;30(13):2288-94. doi: 10.1016/j.vaccine.2012.01.067. Epub 2012 Feb 3.

PMID:
22306795
16.

Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.

Principi N, Terranova L, Zampiero A, Montinaro V, Ierardi V, Peves Rios W, Pelucchi C, Esposito S.

Pediatr Infect Dis J. 2015 Apr;34(4):426-32. doi: 10.1097/INF.0000000000000637.

PMID:
25760567
17.

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.

Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T.

Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Review.

18.

Carriage of Haemophilus influenzae is associated with pneumococcal vaccination in Italian children.

Camilli R, Vescio MF, Giufrè M, Daprai L, Garlaschi ML, Cerquetti M, Pantosti A.

Vaccine. 2015 Aug 26;33(36):4559-64. doi: 10.1016/j.vaccine.2015.07.009. Epub 2015 Jul 16.

PMID:
26190092
19.

Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities.

Millar EV, Pimenta FC, Roundtree A, Jackson D, Carvalho Mda G, Perilla MJ, Reid R, Santosham M, Whitney CG, Beall BW, O'Brien KL.

Clin Infect Dis. 2010 Dec 1;51(11):1258-65. doi: 10.1086/657070. Epub 2010 Oct 29.

PMID:
21034194
20.

Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.

Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.

Pediatr Infect Dis J. 2009 Apr;28(4):277-82. doi: 10.1097/INF.0b013e31818e0e2e.

PMID:
19258924

Supplemental Content

Support Center